Derek DiRocco's Insider Trades & SAST Disclosures
Derek DiRocco's most recent trade in Mineralys Therapeutics Inc was a trade of 32,900 Stock Option done . Disclosure was reported to the exchange on Feb. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Derek DiRocco.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 56,400 | 56,400 | - | - | Stock Option (Right to Buy) | |
| Acrivon Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Werewolf Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Mineralys Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 45,150 | 45,150 | - | - | Stock Option (Right to Buy) | |
| Werewolf Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 13,200 | 13,200 | - | - | Stock Option (right to buy) | |
| ITeos Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 22,383 | 22,383 | - | - | Stock Option (Right to Buy) | |
| Mineralys Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Common Stock | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 27,400 | 27,400 | - | - | Stock Option (Right to Buy) | |
| Acrivon Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 35,235 | 35,235 | - | - | Stock Option (Right to Buy) | |
| Werewolf Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,600 | 11,600 | - | - | Stock Option (right to buy) | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 16,608 | 0 | - | - | Stock Option (Right to Buy) | |
| Werewolf Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Stock Option (right to buy) | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| ITeos Therapeutics Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 16,608 | 0 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2020 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) | |
| 89bio Inc | Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2020 | 7,000 | 7,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges